Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Predictors of post-COVID symptoms in Egyptian patients: Drugs used in COVID-19 treatment are incriminated

  • The PLOS ONE Staff

There are errors in the author affiliations. The publisher apologizes for the errors. The correct affiliations are as follows:

Ahmed Samir Abdelhafiz1, Asmaa Ali2,6, Ayman Mohamed Maaly3, Mohamed Anwar Mahgoub4, Hany Hassan Ziady5, Eman Anwar Sultan5

1 Department of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt, 2 Department of Pulmonary Medicine, Abbassia Chest Hospital, MOH, Cairo, Egypt, 3 Department of Anaesthesia and Surgical Intensive Care, Faculty of Medicine, Alexandria University, Alexandria, Egypt, 4 Department of Microbiology, High Institute of Public Health, Alexandria University, Alexandria, Egypt, 5 Department of Community Medicine, Faculty of Medicine, Alexandria University, Alexandria, Egypt, 6 Department of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China

Reference

  1. 1. Abdelhafiz AS, Ali A, Maaly AM, Mahgoub MA, Ziady HH, Sultan EA (2022) Predictors of post-COVID symptoms in Egyptian patients: Drugs used in COVID-19 treatment are incriminated. PLoS ONE 17(3): e0266175. https://doi.org/10.1371/journal.pone.0266175 pmid:35358268

Citation: The PLOS ONE Staff (2022) Correction: Predictors of post-COVID symptoms in Egyptian patients: Drugs used in COVID-19 treatment are incriminated. PLoS ONE 17(7): e0271154. https://doi.org/10.1371/journal.pone.0271154

Published: July 5, 2022

Copyright: © 2022 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.